Product Information
DESMOPRESSIN 40 MCG/10 ML VIAL is a generic product labeled by Sagent Pharmaceuticals, priced at $19.1479 per ML under NDC 25021046110. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on Aug 22, 2017. Its Orange Book therapeutic-equivalence code is AP.
Strength
40 ug/10mL
Manufacturer
Sagent PharmaceuticalsNDC
25021046110
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAVENOUS; SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
DESMOPRESSIN ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA204751FDA Approved
8/22/2017
TE Code
AP
On Market Since
3/15/2018
Pharmacological Classes
Price Statistics
The NADAC for DESMOPRESSIN 40 MCG/10 ML VIAL has been published 129 times since Apr 17, 2024, and over the history we have for it it has declined 39.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $19.1479 per ML |
|---|---|
| All-time high | $32.3369 (Jun 12, 2024) |
| All-time low | $17.7125 (Dec 17, 2025) |
| 52-week high | $20.8637 |
| 52-week low | $17.7125 |
| Median price | $19.4503 |
| Average price | $21.5802 |
| Largest weekly change | -19.6% (Sep 18, 2024) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the desmopressin acetate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sagent Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
desmopressin acetate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Factor VIII Activator class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DESMOPRESSIN 40 MCG/10 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for DESMOPRESSIN 40 MCG/10 ML VIAL, manufactured by Sagent Pharmaceuticals, is $19.1479 per ML (NDC 25021046110), effective Sep 30, 2026.
How has the price of DESMOPRESSIN 40 MCG/10 ML VIAL changed over time?
Over the history we have for it, the NADAC for DESMOPRESSIN 40 MCG/10 ML VIAL has declined 39.4%. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for DESMOPRESSIN 40 MCG/10 ML VIAL?
Since Apr 17, 2024, the NADAC for DESMOPRESSIN 40 MCG/10 ML VIAL has ranged from a low of $17.7125 (Dec 17, 2025) to a high of $32.3369 (Jun 12, 2024), with a median of $19.4503 per ML.
Are there cheaper alternatives to DESMOPRESSIN 40 MCG/10 ML VIAL?
No other NADAC-published product currently shares the active ingredient and strength of DESMOPRESSIN 40 MCG/10 ML VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DESMOPRESSIN 40 MCG/10 ML VIAL?
DESMOPRESSIN 40 MCG/10 ML VIAL (NDC 25021046110) is labeled by Sagent Pharmaceuticals, and CMS classifies it as a generic product.